In multivariable Cox regression analysis, KRAS/TP53 mutation status was no longer significantly associated with shorter OS, unlike other included independent variables (age, clinical stage of metastatic disease, and PD-L1 TPS). Here, TP53 is linked to metastatic neoplasm.